FactSet Research Systems: AI Integration Underestimated, Says Baron Capital
Money

FactSet Research Systems: AI Integration Underestimated, Says Baron Capital

authorBy T. Harv Eker
DateAug 17, 2026
Read Time2 min

Baron Capital's Q2 2026 investor letter reveals the impressive performance of its Baron Partners Fund, which saw a 16.61% gain for institutional shares in Q2, surpassing both the Russell Midcap Growth Index and the Russell 3000 Index. Over the year, the Fund delivered a 48.75% return, significantly outperforming its benchmarks. This success stems from a concentrated portfolio of 28 companies, with the top 10 holdings making up 74.1% of investments. The strategy targets growth businesses expected to double in value within 5-6 years, leveraging in-depth research to identify sustainable growth opportunities and competitive advantages, often employing strategic leverage to amplify returns.

A key focus in Baron Partners Fund's letter was FactSet Research Systems Inc. (FDS), a prominent provider of financial data and analytical tools. Despite a 6.34% rise in Q2 2026, contributing 0.31% to the Fund's performance, FDS shares have faced market skepticism due to perceived risks from AI disruption. Baron Capital, however, contends that the market is misjudging FactSet's crucial role as AI becomes more deeply embedded in financial operations. They see FactSet as an essential AI infrastructure component within the industry, noting its 7% organic annual subscription value growth and significant client expansions driven by AI, including a major bank doubling its data subscriptions. Additionally, a strategic alliance with Google Cloud to integrate Gemini AI models into FactSet's workstation underscores its forward-looking approach. Currently, FDS is trading at a substantial discount compared to its historical average multiples, and management has been actively engaged in share repurchases, amounting to $163 million in the latest quarter.

Baron Capital emphasizes that the firm's portfolio has historically weathered periods of investor skepticism when companies reinvest in their operations or resolve underlying issues. The Fund's diversified yet concentrated structure allows it to mitigate company-specific and sector-specific challenges, demonstrating its resilience through the substantial outperformance of its Disruptive Growth holdings in the recent quarter. While FactSet isn't on the list of most popular stocks among hedge funds, Baron Capital's analysis suggests its strategic AI integrations and undervalued status present a compelling investment case, particularly for those seeking long-term growth in the evolving financial technology landscape.

The strategic integration of artificial intelligence by companies like FactSet Research Systems reflects a forward-thinking approach that transforms industry challenges into growth opportunities. This adaptability and commitment to innovation are crucial for sustained success in dynamic markets. Investors who recognize and support such visionary companies contribute to a future where technology empowers progress and drives economic expansion.

More Articles
Money
Claude AI Invests in Uber: A Deep Dive into the 'Boring, Not Broken' Stock
Claude AI, participating in a real-money stock trading experiment, has acquired shares in Uber (NYSE:UBER), describing the company's stock as 'boring, not broken'. This move follows Claude AI's impressive performance, outperforming the S&P 500. The AI's investment is backed by Uber's robust financial metrics, including strong revenue growth, substantial operating cash flow, and a vast global user base. This article explores the AI's rationale and the contrasting perspectives of bullish and bearish investors regarding Uber's future prospects.
By Natalie PaceAug 17, 2026
Money
HIVE Digital's Stock Surges on Major Nvidia AI Deal
HIVE Digital's stock saw a significant 14% surge following the announcement of a substantial AI cloud computing contract with chip giant Nvidia. This five-year agreement, valued at $350 million, marks HIVE's largest AI deal to date and is expected to substantially boost its annual recurring revenue, bringing it closer to its $200 million target. The partnership solidifies HIVE's strategic shift towards AI and high-performance computing services.
By Chika UwazieAug 17, 2026
Money
Retirement Planning: Unlocking Savings Before 59½ with Roth Conversion Ladders
For those aiming to retire early, specifically before age 59½, accessing retirement funds from traditional accounts can lead to penalties. A Roth conversion ladder offers a potential solution by systematically converting traditional IRA assets to a Roth IRA. This strategy involves a five-year waiting period for each conversion, after which the converted principal can be withdrawn without early withdrawal penalties. However, careful planning is essential to manage taxable income during conversions and to bridge the financial gap before funds become accessible.
By Mr. Money MustacheAug 17, 2026
Money
Attovia Therapeutics: Pioneering Solutions for Chronic Itch with Innovative Biologics
Attovia Therapeutics, leveraging its proprietary Attobody platform, is making strides in clinical-stage biotechnology. The company focuses on developing next-generation biologics to combat chronic itch, with its lead candidate, ATTO-1310, targeting the 'itch cytokine' IL-31. Despite its recent public market debut and current stock performance, Attovia's innovative pipeline and substantial funding position it as a key player in immunology, aiming to redefine treatment for various pruritic conditions.
By Mr. Money MustacheAug 17, 2026
Money
Cavendish Elevates Optima Health Target Following Strong Annual Performance
Cavendish has increased its price target for Optima Health PLC after the occupational health provider surpassed its annual profit forecasts. This revision reflects growing confidence in Optima Health's strategic medium-term objectives, following a successful year and significant acquisitions that have cemented its market leadership.
By Chika UwazieAug 17, 2026